Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit® APC-R Factor V Leiden) at two centers in Europe and the USA

Thrombosis Research

Volumn 119, Issue 1, 2007, Pages 17-26

  Schöni, Reto ^a   Quehenberger, Peter ^b   Wu, Jogin R ^c   Wilmer, Marianne ^a  

^a Pentapharm Ltd   (Switzerland)

^b UNIVERSITY OF VIENNA   (Austria)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

APC resistance; APC R; Clinical Study; COATEST ; FV Leiden

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; CARRIER PROTEIN; LUPUS ANTICOAGULANT; MUTANT PROTEIN; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ANALYTIC METHOD; ARTICLE; FUNCTION TEST; INTERMETHOD COMPARISON; LABORATORY TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN DEGRADATION; PROTEIN S DEFICIENCY; SAMPLING; SCREENING; SENSITIVITY AND SPECIFICITY; THROMBOPHILIA;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMISTRY, CLINICAL; CHILD; EUROPE; FACTOR V; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTHROMBIN; SENSITIVITY AND SPECIFICITY; THROMBOPHILIA; UNITED STATES;

EID: 33750812822     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.06.015     Document Type: Article

References (14)

1. Dahlbäck B., Carlsson M., and Svensson P. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90 (1993) 1004-1008
2. Press R., Bauer K., Kujovich J., and Heit J. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 126 (2002) 1304-1318
3. Tripodi A. Laboratory diagnosis of thrombophilic states: where do we stand?. Pathophysiol Haemost Thromb 32 (2002) 245-248
4. Tripodi A., Negri B., Bertina R., and Mannucci P. Screening for the FV:Q506 mutation-evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis. Thromb Haemost 77 (1997) 436-439
5. Zehnder J., and Benson R. Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden. Am J Clin Pathol 106 (1996) 107-111
6. Quenhenberger P., Handler S., and Mannhalter C. Evaluation of a highly specific functional test for the detection of factor V Leiden. Int J Clin Lab Res 30 (2000) 113-117
7. Wilmer M., Stocker C., Bühler B., Conell B., and Calatzis A. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay. Am J Clin Pathol 122 (2004) 836-842
8. Kapiotis S.Q.P., Jilma B., Handler S., Pabinger-Fasching I., Mannhalter C., and Speiser W. Improved characteristics of a aPC-resistance assay COATEST aPC resistance by predilution of samples with factor V deficient plasma. Am J Clin Pathol 106 (1996) 588-593
9. Sayinalp N., Haznedaroglu I., Aksu S., Büyükasik Y., Göker H., Parlak H., Özcebe I., Kirazli S., Dündar S., and Gürgey A. The predictability of factor V Leiden (FV:Q506) gene mutation via clotting based diagnosis of activated protein C resistance. Clin Appl Thromb Hemost 10 (2004) 265-270
10. Nicolaes G., and Dahlbäck B. Factor V and thrombotic disease-description of a Janus-faced protein. Arterioscler Thromb Vasc Biol 22 (2002) 530-538
11. Ortiz A. Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family. Thromb Haemost 93 (2005) 1193-1195
12. van der Neut Kolfschoten M., Dirven R., Tans G., Rosing J., Vos H., and Bertina R. The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma model. Blood Coagul Fibrinolysis 13 (2002) 207-215
13. Mingozzi F, Legnani C, Lunghi B, Scanavini D, Castoldi E, Palareti G, Marchetti G, Bernardi F. A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers. 2003; 89: 983-989.
14. Quehenberger P., Handler S., Mannhalter C., Kyrle P.A., and Speiser W. The factor V (Leiden) test: evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the Factor V Leiden mutation. Thromb Res 96 (1999) 125-133